# Truist Financial

Type: Company

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/truist-financial
Canonical HTML page: https://getbiobrief.com/entity/truist-financial

## Recent coverage (1 stories)

### COLL Q2 EPS Beats by $0.20; Revenue Up 6.3% to $199.88M
2026-08-09 18:28:47 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Collegium Pharmaceutical's earnings beat of $0.20 per share, reaching $1.92 on $199.88M revenue, highlights its commercial success in the abuse-deterrent opioid space, a key sector for the biopharma industry.
Full story: https://getbiobrief.com/story/collegium-pharma-q2-2026-earnings-bio

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.